Comparison of Valveplasty and Replacement for Surgical Treatment of Infective Tricuspid Valve Endocarditis

Abstract Background In recent years, due to the increase in intravenous drug injection and intracardiac and vascular interventional treatments among drug users, infective endocarditis involving the right heart of the tricuspid valve has gradually increased.At present, there is no systematic report on surgical treatment of tricuspid infective endocarditis. This paper summarizes the experience of surgical treatment of 56 patients with tricuspid infective endocarditis in our hospital and analyzes its clinical effect. Methods From January 2006 to August 2019, 56 cases of tricuspid infective endocarditis treated by tricuspid valve surgery in our hospital were analyzed retrospectively.including 23 cases of tricuspid valvuloplasty (TVP) and 33 cases of tricuspid valve replacement (TVR). All patients were complicated with tricuspid valve vegetations or moderate and severe tricuspid regurgitation and had surgical indications.The perioperative data were collected and followed up for 6 months to 14 years to summarize and analyze the clinical effect of surgical treatment of tricuspid infective endocarditis. Results Compared with TVR group, the CPB time (79.68 ± 19.02min VS 107.39 ± 25.64min, P < 0.01), ACC time (50.29 ± 16.14min VS 65.52 ± 20.62min, P < 0.01), postoperative mechanical ventilation time (18.65 ± 8.18h VS 44.85 ± 57.68h, P < 0.01) and ICU stay time (38.13 ± 21.80h VS 102.64 ± 142.11h, P = 0.015) in TVP group were shorter. The perioperative red blood cell transfusion (4.87 ± 3.81U VS 7.55 ± 5.42U, P < 0.01) and the incidence of postoperative complications (8.7% VS 33.3%, P < 0.01) were lower.Perioperative death occurred in 1 case in the TVR group, and there was no perioperative death in the TVP group, There was no significant difference between the two groups(3.03% VS 0, P = 0.855). A total of 52 cases were followed up for an average of (5.50 ± 3.79) years.The postoperative 3-year, 5-year and 7-year survival rate were 100%,100%,91.7% in TVP group and 95.2%, 93.8% and 87.5%.The 5-year and 10-year reoperation rate were 0%, 0% in TVP group and 6.7%, 20% in TVR group. Conclusion Surgical treatment of severe tricuspid valve endocarditis has achieved good mid-term clinical results, and the rate of avoiding reoperation is better in TVP group than in TVR group.

Download Full-text

Isolated Native Tricuspid Valve Endocarditis in a Nonintravenous Drug User

Case Reports in Cardiology ◽

10.1155/2020/8812597 ◽

2020 ◽

Vol 2020 ◽

pp. 1-4

Author(s):

Habtewold Shibru ◽

Ermias shenkutie Greffie ◽

Zenahbezu Abay ◽

Oumer Abdu Muhie

Keyword(s):

Infective Endocarditis ◽

Tricuspid Valve ◽

Drug Users ◽

High Morbidity ◽

Central Venous ◽

Cardiac Device ◽

Rural Ethiopia ◽

Cardiac Devices ◽

Underlying Risk ◽

Tricuspid Valve Endocarditis

Infective endocarditis (IE) is a disease characterized by high morbidity and mortality. IE was first described in the mid-16th century. Right-sided infective endocarditis (RSIE) represents 5% to 10% of all IE episodes in adults. RSIE can be divided into three groups according to the underlying risk factors: intravenous drug users (IDUs), cardiac device carriers, and the “three noes” group (no left-sided IE, no IDUs, and no cardiac devices). Tricuspid valve endocarditis in nonintravenous drug users can occur in a variety of conditions including congenital heart disease, intracardiac devices, central venous catheters, and immunologically debilitated patients. Due to the rareness of isolated native nonrheumatic tricuspid valve endocarditis, here, we like to present an 18-year-old male from rural Ethiopia with the diagnosis of isolated native tricuspid valve endocarditis that was treated and cured.

Download Full-text

Clinical outcomes of percutaneous debulking of tricuspid valve endocarditis in intravenous drug users

Catheterization and Cardiovascular Interventions ◽

10.1002/ccd.29584 ◽

2021 ◽

Author(s):

Yasir N. Akhtar ◽

William A. Walker ◽

Umar Shakur ◽

Gary Smith ◽

Syed S. Husnain ◽

...

Keyword(s):

Clinical Outcomes ◽

Tricuspid Valve ◽

Drug Users ◽

Intravenous Drug ◽

Intravenous Drug Users ◽

Tricuspid Valve Endocarditis

Download Full-text

Optimum surgical treatment for tricuspid valve infective endocarditis: An analysis of the Society of Thoracic Surgeons national database

Journal of Thoracic and Cardiovascular Surgery ◽

10.1016/j.jtcvs.2019.10.124 ◽

2019 ◽

Cited By ~ 9

Author(s):

Mark S. Slaughter ◽

Vinay Badhwar ◽

Mickey Ising ◽

Brian L. Ganzel ◽

Kristen Sell-Dottin ◽

...

Keyword(s):

Surgical Treatment ◽

Infective Endocarditis ◽

Tricuspid Valve ◽

National Database

Download Full-text

Tricuspid Valve Excision Complicated by Postoperative Gerbode Defect Following Recurrent Infective Endocarditis: A Case Report

Seminars in Cardiothoracic and Vascular Anesthesia ◽

10.1177/1089253220952260 ◽

2020 ◽

pp. 108925322095226

Author(s):

Jasdeep S. Dhaliwal ◽

Michael J. Wadle ◽

Rajasekhar Malyala ◽

Sanjay Dwarakanath ◽

Kevin W. Hatton

Keyword(s):

Infective Endocarditis ◽

Tricuspid Valve ◽

Surgical Intervention ◽

Critically Ill Patient ◽

Opioid Epidemic ◽

Intravenous Drug Use ◽

Recurrent Infections ◽

Number Of Patients ◽

Gerbode Defect ◽

Tricuspid Valve Endocarditis

Tricuspid valve infective endocarditis is an increasingly common sequela of the opioid epidemic. While often managed medically, certain subsets of patients will require surgical intervention, including repair, replacement, and possibly even excision. Historically, simple valvectomy was performed in instances of recidivism and reinfection; however, reoperation and replacement has become the preferred treatment in the current era. Given the increasing incidence of intravenous drug use and the increase in the number of patients presenting with recurrent infections, simple valvectomy has regained favor in recent years. In this article, we present the management of a critically ill patient with recurrent tricuspid valve endocarditis who underwent tricuspid valvectomy that was complicated by a left ventricle to right atrium fistula and discuss some of the most important perioperative issues and complications for patients who undergo tricuspid valvectomy.

Download Full-text

Surgical Treatment for Tricuspid Valve Infective Endocarditis

Advanced Concepts in Endocarditis ◽

10.5772/intechopen.74951 ◽

2018 ◽

Author(s):

Takashi Murashita

Keyword(s):

Surgical Treatment ◽

Infective Endocarditis ◽

Tricuspid Valve

Download Full-text

Surgical and Medical Management of Isolated Tricuspid Valve Infective Endocarditis in Intravenous Drug Users

Journal of Cardiac Surgery ◽

10.1111/jocs.12682 ◽

2015 ◽

Vol 31 (2) ◽

pp. 83-88 ◽

Cited By ~ 9

Author(s):

Nabha Shetty ◽

Dave Nagpal ◽

Sharon Koivu ◽

Marko Mrkobrada

Keyword(s):

Infective Endocarditis ◽

Tricuspid Valve ◽

Medical Management ◽

Drug Users ◽

Intravenous Drug ◽

Intravenous Drug Users

Download Full-text

Long-Term Outcome for the Surgical Treatment of Infective Endocarditis With a Focus on Intravenous Drug Users

The Annals of Thoracic Surgery ◽

10.1016/j.athoracsur.2011.08.016 ◽

2012 ◽

Vol 93 (1) ◽

pp. 51-57 ◽

Cited By ~ 59

Author(s):

David G. Rabkin ◽

Nahush A. Mokadam ◽

Donald W. Miller ◽

Raymond R. Goetz ◽

Edward D. Verrier ◽

...

Keyword(s):

Surgical Treatment ◽

Infective Endocarditis ◽

Drug Users ◽

Intravenous Drug ◽

Intravenous Drug Users ◽

Term Outcome ◽

Long Term Outcome

Download Full-text

Surgical treatment of multi-valve heart disease of infective endocarditis

Azerbaijan Journal of Cardiovascular Surgery ◽

10.30546/azjcvs.2021.2.1.40 ◽

2021 ◽

pp. 40-49

Author(s):

Khamidulla ABDUMADJIDOV ◽

Hijran BURANOV ◽

Iskender BAYBEKOV ◽

Bois SAIDKHANOV ◽

Abdulla ALIMDJANOV

Keyword(s):

Heart Disease ◽

Surgical Treatment ◽

Infective Endocarditis ◽

Preventive Measures ◽

Clinical Results ◽

Control Group ◽

Study Group ◽

X Rays ◽

Infected Area ◽

Valve Heart Disease

Peculiarities of diagnosis and results of surgical treatment of multi-valve heart disease in infective endocarditis. Analyze data and clinical results operated 156 patients with infective endocarditis, of which 85 were men (56.5%), and women -71 (45.5%). Age Our patients ranged from 12 to 68 (mean 32.76 ± 1.6) years. Diagnosis was based on the classiϐication and criteria Durack D.T. The patients were divided into 2 groups: group 1, 89 (57.4%) patients who underwent a complex developed by the authors of antibiotic therapy, treatment and preventive measures. 2-group 67 (42.6%) patients who underwent the traditional surgical treatment scheme. The diagnosis used: electrocardiography (ECG), X-rays from Skopje, transthoracic echocardiography (TTEHOKG) - all patients, transesophageal echocardiography (TEHOKG) - at 40.5%; coronaroventriculography (CVG) and angiocardiography (ACG) - at 12.65%; blood culture study in 38.6% of patients, with light gistrology electron microscopy (LEM) - in 47.5% of patients.Intraoperative treatment - preventive measures (TPM) were as follows; mechanical and chemical sanitation of the infected area of the heart; valve implantation antibakteriyalnymi properties; hyperthermic perfusion; anti microbial therapy, including anti-fungal agents. Application of the above measures could reduce mortality in the study group and 5.1% in the control group - 9.3%. In dynamics, declined to 3.9% in the last Godi mortality in the study group.

Download Full-text